Health

FDA Grants Accelerated Approval to Zegfrovy (sunvozertinib) for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

DailyTrendDailyTrend
Jul 8, 2025 - 17:00
 0  0
FDA Grants Accelerated Approval to Zegfrovy (sunvozertinib) for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
July 2, 2025 – Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today that the U.S. Food and Drug Administration (FDA) has approved...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

FDA Approves Alhemo as Once-Daily Prophylactic Treatment to Prevent or Reduce the Frequency of Bleeding Episodes for Adults and Children 12 Years of Age and Older with Hemophilia A or B (HA/HB) Without Inhibitors

FDA Approves Alhemo as Once-Daily Prophylactic Treatmen...

DailyTrend Aug 3, 2025  0  0

Early Alert: Defibrillation Lead Issue from Boston Scientific

Early Alert: Defibrillation Lead Issue from Boston Scie...

DailyTrend Aug 6, 2025  0  0

A Cancer Patient Chose Assisted Death. That Wasn’t the Last Hard Choice.

A Cancer Patient Chose Assisted Death. That Wasn’t the ...

DailyTrend Aug 3, 2025  0  0

Early Alert: Electrophysiology Catheter Issue from Medline ReNewal

Early Alert: Electrophysiology Catheter Issue from Medl...

DailyTrend Aug 6, 2025  0  0

FDA Approves Vostally (ramipril) Oral Solution for the Treatment of Hypertension in Adults

FDA Approves Vostally (ramipril) Oral Solution for the ...

DailyTrend Aug 4, 2025  0  0

The 2 Beliefs Driving Conservative Health Care Policy

DailyTrend Aug 1, 2025  0  0